Results of a Pharmacist Intervention on Weight Parameters and A1c Compared to Standard Patient Care

Abstract

Obesity is linked to many accompanying comorbidities and has a substantial effect on the cost of health care. Pharmacist are able to provide management and intervention for the treatment of these disease states. This study examined outcomes 12 months prior to pharmacist intervention and 6 months postintervention. The primary outcome was to determine if pharmacist service intervention resulted in improved markers of weight and diabetes. This study revealed significant improvement in the HgbA1c and body mass index (BMI) from baseline (A1c 7.9%, BMI 35.3 kg/m²) to postintervention (A1c 7%, BMI 34.1 kg/m²). These results were statistically significant (P < .001, Bonferroni correction applied for multiple comparisons), indicating the clinical importance of adding pharmacists to the health care team in obesity and diabetes management.

Keywords

type 2 diabetes obesity pharmaceutical care clinical practice clinical pharmacy

Get full access to this article

View all access options for this article.

References

Center for Disease Control and Prevention. Overweight & obesity: data and statistics. www.cdc.gov/obesity/data/index.html. Accessed May 10, 2018.

Finkelstein

Trogdon

Cohen

Dietz

Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood). 2009;28:w822-w831. doi:10.1377/hlthaff.28.5.w822.

Ogden

Carroll

Fryar

Flegal

Prevalence of obesity among adults and youth: United States, 2011-2014. NCHS Data Brief. 2015;(219):1-8.

Center for Disease Control and Prevention. Adult obesity facts. www.cdc.gov/obesity/data/adult.html. Accessed May 10, 2018.

US Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People 2020: nutrition and weight status. https://www.healthypeople.gov/2020/topics-objectives/topic/nutrition-and-weight-status. Accessed May 10, 2018.

Bush

Langley

Mills

Hindle

A comparison of the provision of the My Choice Weight Management Programme via general practitioner practices and community pharmacies in the United Kingdom. Clin Obes. 2014;4:91-100. doi:10.1111/cob.12049.

Lloyd

Thrower

Walters

Krueger

Stamm

Evans

RL.

Implementation of a weight management pharmaceutical care service. Ann Pharmacother. 2007;41:185-192. doi:10.1345/aph.1E466.

Malone

Alger-Mayer

Anderson

DA.

The Lifestyle Challenge Program: a multidisciplinary approach to weight management. Ann Pharmacother. 2005;39:2015-2020. doi:10.1345/aph.1G287.

American Diabetes Association. Treatment and care. http://www.diabetes.org/living-with-diabetes/treatment-and-care/?loc=lwd-slabnav. Accessed May 10, 2018.